Related Experiment Videos
Monocyte membrane ferritin in hemochromatosis
P C Adams1, P R Flanagan, L Chau
1Department of Medicine, University Hospital, University of Western Ontario, London.
Summary
Monocytes in hemochromatosis patients show increased surface ferritin, suggesting a metabolic defect. This finding differentiates hemochromatosis from secondary iron overload, aiding in diagnosis.
Area of Science:
- Immunology
- Hematology
- Gastroenterology
Background:
- Hemochromatosis is characterized by iron overload.
- Reticuloendothelial cells may play a role in hemochromatosis pathophysiology.
- Ferritin is the primary intracellular iron-storage protein.
Purpose of the Study:
- To investigate potential abnormalities in reticuloendothelial cells in hemochromatosis.
- To evaluate the binding of anti-human liver ferritin antibody to monocytes in various iron overload conditions.
- To differentiate hemochromatosis from secondary iron overload based on monocyte ferritin expression.
Main Methods:
- Monoclonal anti-human liver ferritin antibody binding to monocytes was assessed.
- Fluorescence-activated cell sorting (FACS) was used for analysis.
- Study included patients with hemochromatosis, secondary iron overload, hyperferritinemia, and healthy volunteers.
Main Results:
- Monocyte binding of anti-ferritin antibody was significantly higher in untreated hemochromatosis patients (34.7%) compared to normal volunteers (4.1%).
- Patients with hemochromatosis showed greater antibody binding than those with secondary iron overload (12.3%), despite similar iron levels.
- Treated hemochromatosis patients (6.75%) and hyperferritinemia patients (4.1%) had lower binding rates.
Conclusions:
- Monocytes from iron-loaded hemochromatosis patients express increased surface ferritin.
- This elevated surface ferritin may indicate ferritin release and a metabolic defect specific to hemochromatosis.
- The findings suggest a potential diagnostic marker for differentiating hemochromatosis from other iron overload states.